All News

FDG,PET,CT

Predictive FDG-PET in Newly Diagnosed GCA

d Jack Cush, MD

Annals of Internal Medicine reports that the use of 18F-fluorodeoxyglucose (FDG) PET imaging at the time of a giant cell arteritis (GCA) diagnosis may help estimate the risk for aortic aneurysm formation.

Read Article
First PMR panel

TNR: PMR Diagnosis and Monitoring

d Jack Cush, MD

Panelists Dr. Claire Owen, Stephen Paget, Anisha Dua and Jack Cush discuss diagnosis and monitoring in PMR during this week's Tuesday Night Rheumatology.

Read Article
gout podagra inflammed

Gout Flare Prophylaxis - Colchicine or NSAIDs?

d Jack Cush, MD

Flare prophylaxis is the standard when initiating urate-lowering therapy (ULT) in patients with gout. A new study suggests that colchicine, more so than non-steroidal anti-inflammatory drug (NSAID) prophylaxis, may increase the odds of adverse events, when initiating allopurinol for gout.

Read Article
US the axillary artery of a patient with polymyalgia rheumatica without cranial symptoms. Three years after diagnosis at the third relapse after tapering glucocorticoids.

Subclinical vasculitis in polymyalgia rheumatica

d Kresten Krarup Keller, MD, PhD

Frequent use of vascular ultrasonography and positron emission tomography and computed tomography (PET/CT) increase the possibility of encountering a patient with solely symptoms of PMR (no cranial symptoms), but giant cell arteritis (GCA) confirmed with imaging. This group of PMR patients with so-called subclinical large vasculitis represents a clinical challenge. 

Read Article
PMR,campaign,Rheum

October is PMR Month

d Jack Cush, MD

PMR has come a long way from being an occasional referral and often test question, to now being a hot area of drug development and investigation. Led by numerous investigators and educators worldwide, there are new insights into the diagnosis, management and outcomes of PMR patients, with greater clarity on how and where it differs from giant cell arteritis.

Read Article
RheumNow Podcast square

RheumNow Podcast – with Special Guest Dr. Kathryn Dao (9.29.2023)

d Jack Cush, MD

This week on the podcast, Dr. Jack Cush is joined by special guest, Dr. Kathryn Dao to review the news and journal reports from the past week on RheumNow.com. They discuss unmet needs in gout, obesity and CV disease in PsA and should you check ANCA antibodies in SLE?

Read Article
WashDC.jpg

Rheumatology Advocates Push for Patient Access to Care

d ACR

Physician members of the American College of Rheumatology (ACR), care team members of the Association of Rheumatology Professionals (ARP), and patients living with rheumatic diseases convened on Capitol Hill this week for the annual Advocates for Arthritis conference and to support legislative so

Read Article
Best quote from last nights Tues Night Rheumatology on #PMR , comes from Dr. Stephen Paget (#HSS) who said, "steroids to a new PMR patient are like spinach to Popeye" https://t.co/r7L1cUTJeT

Links:

Dr. John Cush RheumNow ( View Tweet)

X-sectional case-cntrl study w/ UK Biobank looked @ comorbidity w #PMR (n=1036) & GCA (102) pts (98% W; age 63 yrs) - pts rated their health as poor. Comorbid Dx included-more hypothyroidism (OR 1.34), HRT use (1.26), HTN (1.21-1.86) & cataract (1.51-3.84) https://t.co/GxpzN5NWug https://t.co/8J0IRMLK5g

Links:

Dr. John Cush RheumNow ( View Tweet)
New download on #PMR available now! https://t.co/C4fCUQ5j8e https://t.co/3Fm5xG8EM7

Links:

Dr. John Cush RheumNow ( View Tweet)
Steroid Tapering in #PMR: What's the Gold Standard? Dr. Anisha Dua, Chicago, discusses the gold standard tapering of glucocorticoids in polymyalgia rheumatica. https://t.co/WyojhJQkN2 https://t.co/NarFqwNxEj

Links:

Dr. John Cush RheumNow ( View Tweet)
Retrospective EHR study of 7,970 gout pts from Singapore finds ~28% are poorly controlled, with only 46% prescribed allopurinol (13% @doses ≥300). Poor control assoc w/ male gender (adj OR 1.66), Malay ethnicity (aOR 1.27), CHF (aOR, 1.64) https://t.co/M8dJFIbZEV https://t.co/aUnLgUmvXN

Links:

Dr. John Cush RheumNow ( View Tweet)
Cardiovascular manifestations of monogenic periodic fever syndromes - includes: - Pericarditis (most common) - Cardiac Amyloidosis - Myocarditis - CV complications of inflammation and steroid - Premature atherosclerosis https://t.co/iLfbPq2nzn https://t.co/T7Vtx5q8Y1

Links:

Dr. John Cush RheumNow ( View Tweet)
October is #PMR Month PMR has come a long way from being an occasional referral and often test question, to now being a hot area of drug development and investigation https://t.co/voVlxuRGZA https://t.co/NwEvws8cD3

Links:

Dr. John Cush RheumNow ( View Tweet)
Diagnosis and Monitoring of PMR https://t.co/D3ml0ZZCpb

Links:

Dr. John Cush RheumNow ( View Tweet)

Excited to join @RheumNow for Tuesday Night Rheumatology and contribute to Make Rheum for #PMR this October🤩 https://t.co/8HqAVPDLXS

Claire Owen  ( View Tweet)

RA QD Clinic - RA in Deep Remission If the patient is in Deep Remission - do you suggest DMARD or biologic weaning? https://t.co/ELV1MTNkrI https://t.co/9wiqvlZUEY

Links:

Dr. John Cush RheumNow ( View Tweet)
1 in 3 of our pts are on steroids; nice ARD full read review of important papers on steroids 2022-23 written by Prof J Bijlsma, covering: Mechanisms of action CV AE Bone Effects Infections, COVID-19 Clin trials Benefit vs Harm Tapering GC Guidelines https://t.co/MAErgj8MGz https://t.co/JDnBUU3FLe

Links:

Dr. John Cush RheumNow ( View Tweet)
Metanalysis of 17 studies (n=862849 pts) looked at fall risk w/ #OA. OA Hip (OR 1.50 & knee (OR 1.55) assoc w/ signif incr risk recurrent falls, but not FX. Xray knee OA w/ incr risk of falls (OR 1.28); Xray hip OA decr risk recurrent falls (OR 0.70) https://t.co/7iD8CDA1L7 https://t.co/Cn8lUt07WG

Links:

Dr. John Cush RheumNow ( View Tweet)
Long-term Safety of a JAKi in Patients with RA With up to 6.5 Years of Exposure View this poster on the long-term integrated safety data with a JAKi in patients with RA from 6 clinical studies. Sponsored by AbbVie US Medical Affairs https://t.co/h9hAaF5Q8d. https://t.co/RfhNioxQrm

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×